CSBR — Champions Oncology Share News
0.000.00%
Last trade - 00:00- $92.07m
- $85.14m
- $56.94m
Champions Oncology Inc expected to post a loss of 10 cents a share - Earnings Preview
Champions Oncology Inc reports results for the quarter ended in April - Earnings Summary
Brief: Champions Biotechnology Inc Qtrly Revenue Increased 2% To $13.1 Million
Champions Oncology Inc expected to post a loss of 12 cents a share - Earnings Preview
Champions Oncology Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Champions Oncology Announces $5 Million Stock Repurchase Program
Champions Oncology Inc reports results for the quarter ended in January - Earnings Summary
Brief: Champions Biotechnology Inc - QTRLY Net Loss Per Common Share Outstanding $0.18
Champions Oncology Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Champions Oncology Says Total Revenue For Q2 Of Fiscal 2023, Was A Record $14.3 Million, An Increase Of 21.2%
Champions Oncology Inc expected to post a loss of 1 cent a share - Earnings Preview
Champions Oncology Inc reports results for the quarter ended in July - Earnings Summary
Brief: Champions Biotechnology Q1 Oncology Services Revenue $13.7 Million Versus $11.3 Million
Champions Oncology Inc reports results for the quarter ended in April - Earnings Summary
Champions Oncology Inc expected to post earnings of 3 cents a share - Earnings Preview
Champions Oncology Inc reports results for the quarter ended in January - Earnings Summary
Champions Oncology Inc expected to post earnings of 3 cents a share - Earnings Preview
Champions Oncology Inc expected to post earnings of 3 cents a share - Earnings Preview
Champions Oncology Inc reports results for the quarter ended in October - Earnings Summary